HAEVN
Live / Applied — Suspended — suspension check completed, case still suspended (as of 30 Dec 2025)
What this means for you
Not registered yet, but its 27 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99020243
- Mark type
- Stylized text
- Filed
- 27 Jan 2025
- Attorney of record
- Brian Focarino
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing healthcare information, medical information, and pharmaceutical information online, by telephone, and through distribution of printed healthcare materials to healthcare providers, patients, physicians, medical office staff, pharmaceutical prescribers, caregivers, and pharmacies regarding patient access to and reimbursement for pharmaceuticals and safe and appropriate use and distribution of pharmaceuticals; providing healthcare information; medical information services; providing a website featuring medical information in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; medical consulting services in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders; healthcare services, namely, providing an online database comprised of medical and healthcare information in the fields of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune lymphoproliferative, asthma, and rare diseases and disorders, and collecting data and information on hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of hereditary angioedema, edema, autosomal dominant, autosomal recessive, genetic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, asthma, and rare diseases and disorders
Owner
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
Prosecution history
- 03 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Dec 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 10 Dec 2025 — AMENDMENT TO USE PROCESSING COMPLETE
- 10 Dec 2025 — USE AMENDMENT FILED
- 10 Dec 2025 — TEAS AMENDMENT OF USE RECEIVED
- 06 Aug 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 06 Aug 2025 — LETTER OF SUSPENSION E-MAILED
- 06 Aug 2025 — SUSPENSION LETTER WRITTEN
- 16 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED